Menu

Home / Guides / Does Blue Cross Blue Shield cover Zepbound?

Blue company by Blue company, dated.

Does Blue Cross Blue Shield Cover Zepbound? By Plan (2026)

By the NexLife Medical Team · Medically reviewed by Adam Kennah, MD (NPI 1144260043) · Updated

Blue Cross Blue Shield covers Zepbound for weight loss only if your Blue plan includes weight-loss drugs, and many don’t: each of the 33 Blue companies sets its own drug coverage, and on job plans your employer often decides. FEP Blue’s 2027 Standard and Basic lists don’t cover Zepbound. Without coverage, compounded tirzepatide through NexLife, which isn’t FDA-approved, is $115 a month on the 12-month plan, or $129 month to month.

  • Job plans: many Blues cover it for weight loss only if your employer adds it
  • FEP Blue 2027: Zepbound not covered on Standard or Basic
  • Medicare: the $50 Bridge covers the Zepbound KwikPen, if you qualify
Published by NexLifeLegitScript-certified
NexLifeSame price at every dose
Illustration of a compounded tirzepatide vial

$115/mo on a 12-month plan, all-inclusive, same price at every dose

Or $129/mo month to month

Self-pay, with no membership fee. A licensed provider decides if it’s right for you

Check my eligibility

About 3 minutes of health questions · No insurance needed · Not prescribed? No charge for medication

See all 4 plans and what a year costs
Compounded tirzepatide, all in, the same price at every dose
PlanPer month12 months at this rate
12-month Most savings$115$1,380
6-month$119$1,428
3-month$125$1,500
Month to month$129$1,548

Month to month costs $168 more over 12 months than the 12-month plan. Plans renew until you cancel. Month to month is billed monthly. The 3-, 6- and 12-month plans are paid upfront at checkout: $375, $714 or $1,380.

4.8 out of 5 on Trustpilot, 407 reviews (read Nov. 15, 2026)LegitScript-certified

Compounded, not FDA-approved. A licensed provider prescribes it only when it offers a significant difference for you. The vial shown is an illustration. Always use the strength on your pharmacy’s label.

  • Licensed U.S. providers
  • LegitScript certified
  • Free expedited shipping
  • HSA, FSA, Affirm, Klarna, Afterpay
  • 24/7 support, real people
  • Filled by Absolute Pharmacy (Lutz, FL) or Boudreaux’s New Drug Store (Lake Charles, LA)

Compounded tirzepatide and semaglutide aren’t FDA-approved and aren’t Zepbound or Wegovy. A licensed provider prescribes them only when they offer a significant difference for you.

The short version

Blue Cross Blue Shield and Zepbound at a glance, by plan type

Blue Cross Blue Shield and Zepbound at a glance, by plan type, from each Blue company’s own notices (checked Nov. 6 to Nov. 18, 2026), FEP Blue’s 2027 drug lists (read Nov. 1, 2026), Medicare.gov and LillyDirect (checked Nov. 15, 2026)
QuestionAnswer
Does Blue Cross Blue Shield cover Zepbound?It depends on your Blue company and plan. Several Blues exclude weight-loss drugs; others cover Zepbound with prior authorization if your plan includes them.
On a job plan?Your employer usually decides. Premera, AZ Blue, Wellmark and BCBSOK (for self-funded groups) cover weight-loss GLP-1s only where the employer elects them or buys a rider.
On an individual plan?It varies: Blue Cross Blue Shield of North Dakota keeps weight-loss drugs on its individual plans; Independence Blue Cross dropped drugs used only for weight loss in 2025.
Federal employee (FEP Blue)?Not in 2027 on Standard or Basic: Zepbound is on the not-covered list, and Wegovy is Tier 3 with prior approval.
On Medicare?Not for weight loss alone. The Bridge covers the Zepbound KwikPen for $50 a month through Dec. 31, 2027, if you qualify.
For sleep apnea?Sometimes reviewed on its own, as at AZ Blue; excluded unless your employer bought a rider at Blue Cross Blue Shield of Massachusetts.
Paying yourself?Zepbound vials are $299 to $449 a month at LillyDirect. Compounded tirzepatide at NexLife is $115 a month on the 12-month plan or $129 month to month; it isn’t FDA-approved.

From each Blue company’s own notices, checked Nov. 6 to Nov. 18, 2026; FEP Blue’s 2027 drug lists, read Nov. 1, 2026; Medicare.gov and LillyDirect, checked Nov. 15, 2026. NexLife’s prices from our plan page.

  1. Tell us about you About 3 minutes of health questions
  2. A licensed provider decides You’re prescribed only if it’s right for you
  3. Your partner pharmacy ships Usually within 1 to 2 business days, free

Loved by our members

Real stories from NexLife members about their care and service.

A selection of 5-star reviews from Trustpilot, quoted in full as written. Results vary from person to person, and weight loss isn’t guaranteed.

★★★★★TrustScore 4.8 out of 5 on Trustpilot407 reviews as of Nov. 15, 2026 · Read them all ↗

  • ★★★★★Read on Trustpilot ↗

    “That’s a real site with good prices and plans!”

    Estefany L.

  • ★★★★★Read on Trustpilot ↗

    “Affordable, quick and easy. They could not have made it a smoother less stressful experience.”

    Andisheh K.

  • ★★★★★Read on Trustpilot ↗

    “Great communication. Easy to work with. They work to set you up for success.”

    Anthony C.

  • ★★★★★Read on Trustpilot ↗

    “Fast delivery and easy to get a hold of when needing to talk with someone!”

    Browneyes

  • ★★★★★Read on Trustpilot ↗

    “So happy with NexLife. Communication has been great, I’m recommending them to all my friends.”

    April

  • ★★★★★Read on Trustpilot ↗

    “Excellent visit. Dr. Kennah was very knowledgeable and helpful and answered all my questions.”

    Ethan B.

  • ★★★★★Read on Trustpilot ↗

    “Fast service great communication!! Willing to work with you!”

    Bon

  • ★★★★★Read on Trustpilot ↗

    “Great service and excellent communication!”

    Gabrielle D.

  • ★★★★★Read on Trustpilot ↗

    “Easy and pricing not bad! Customer service was helpful in answering my questions.”

    Lyndy T.

  • ★★★★★Read on Trustpilot ↗

    “Good experience, great team”

    Mai S.

  • ★★★★★Read on Trustpilot ↗

    “Great communciation and was fast and reliable”

    Kiki

  • ★★★★★Read on Trustpilot ↗

    “Very happy so far”

    Tammy E.

Names are shortened for privacy. Reviews are members’ opinions, not medical advice.

Key takeaways

  • No single Blue answer: the 33 independent Blue companies set their own drug coverage, and on job plans your employer often decides (BCBSA).
  • Several exclude it: Florida Blue (in a January 2025 notice) and Blue Cross and Blue Shield of Vermont (since Jan. 1, 2026) don’t cover weight-loss drugs; Blue Cross Blue Shield of Massachusetts does only if your employer buys a rider.
  • Others leave it to your plan: Premera, AZ Blue, Wellmark and BCBSOK (for self-funded groups) cover weight-loss GLP-1s only if the employer elects them or buys a rider.
  • FEP Blue, 2027: Standard and Basic list Zepbound as not covered; Wegovy is Tier 3 with prior approval (drug lists read Nov. 1, 2026).
  • Medicare: the GLP-1 Bridge covers the Zepbound KwikPen for $50 a month through Dec. 31, 2027, if you qualify.
  • Paying yourself? Compounded tirzepatide through NexLife, not FDA-approved, is $115 a month on the 12-month plan. NexLife is self-pay and doesn’t bill Blue plans.

The answer

Does Blue Cross Blue Shield cover Zepbound?

Only if your Blue plan includes weight-loss drugs, and many don’t. Each Blue company writes its own drug lists, and on job plans the employer often decides whether weight-loss drugs are covered. Where they are, expect prior authorization. Zepbound’s sleep apnea use is sometimes a separate question.

“Most plans do not cover medications to achieve weight loss or gain.”

AZ Blue (Blue Cross Blue Shield of Arizona), Weight Loss Drug List, revised Nov. 5, 2026; checked Nov. 6, 2026

A listed drug can still be excluded. Anthem’s National Drug List, current Oct. 1, 2026, shows Zepbound on tier 2 with prior authorization and quantity limits but flags a possible benefit exclusion, so your plan’s design decides. Blue Cross and Blue Shield of Illinois says its Zepbound coverage “is group-specific and not standard” (both checked Nov. 6, 2026).

Which Blue plan types cover Zepbound?

Your plan type decides who makes the call.

By plan type, from the Blue companies’ notices (dated in the company table), FEP Blue’s 2027 drug lists (read Nov. 1, 2026) and Medicare.gov.
If you haveZepbound for weight lossWho decides
A job plan, self-fundedyour employer pays the claimsOnly if your employer elects weight-loss drug coverage, as BCBSOK (May 22, 2026), Premera (Feb. 19, 2026) and Blue Cross Blue Shield of North Dakota (Aug. 7, 2025) say.Your employer
A job plan, fully insuredthe Blue company carries the riskOften excluded: Blue Cross Blue Shield of Michigan dropped it for fully insured large groups on Jan. 1, 2025 or at renewal, and North Dakota’s Blue at renewals from Jan. 1, 2026. Some Blues sell employers a rider that adds it back.The Blue company, plus any rider
An individual or small-group planHealthCare.gov or a state exchangeIt varies: North Dakota’s Blue keeps weight-loss drugs on these plans under state rules; Independence Blue Cross dropped drugs used only for weight loss on Jan. 1, 2025.The Blue company and your state’s rules
FEP Bluefederal employees and retireesNot covered on Standard or Basic in 2027; Wegovy is Tier 3 with prior approval. Focus lists neither.The FEP plan, under OPM’s rules
Medicare Advantage or Part Da Blue Medicare planNot for weight loss alone. Medicare’s GLP-1 Bridge covers the KwikPen for $50 a month through Dec. 31, 2027, if you qualify.CMS, for the Bridge
Medicaida Blue-branded Medicaid planIn Indiana, Ohio and South Carolina, Blue Medicaid plans use the state’s single drug list, like every other plan there (checked Nov. 15, 2026).Your state

Swipe the table sideways to see every column.

By plan type, from the Blue companies’ notices (dated in the company table), FEP Blue’s 2027 drug lists (read Nov. 1, 2026) and Medicare.gov.

Not on a Blue plan? Read how Aetna, Cigna and UnitedHealthcare handle Zepbound, or which weight-loss drugs insurance covers.

By company

What does each Blue company say about Zepbound?

Most of the 22 Blue companies below leave Zepbound for weight loss to your plan’s design, and several exclude it outright. Each row is the company’s own rule, with its date. Find yours by the name on your member card, or by ZIP code on BCBS.com. Not listed: other Blue companies, such as Blue Cross and Blue Shield of Texas, where we found no public Zepbound policy (searched Nov. 18, 2026), and Blue Cross and Blue Shield of North Carolina, which we haven’t reviewed here. If yours isn’t listed, check your plan’s drug list.

What 22 Blue companies and FEP Blue say about Zepbound for weight loss, with each policy’s date and the date we checked it. Your plan documents decide.
Blue companyZepbound for weight lossDate and source
Anthem Blue Cross and Blue Shield14 states, from California to WisconsinTier 2 with prior authorization and quantity limits on its National Drug List, but flagged as a possible benefit exclusion, so your plan’s design decides. Its Georgia individual drug lists for 2026 and 2027 leave Zepbound off.National Drug List, current Oct. 1, 2026; Georgia individual list; checked Nov. 6, 2026
AZ BlueBlue Cross Blue Shield of ArizonaSays most plans don’t cover weight-loss drugs. On its standard list, Zepbound is excluded unless your employer bought the Weight Loss Rider; a separate guideline covers Zepbound for sleep apnea.Weight Loss Drug List, revised Nov. 5, 2026; coverage guidelines; checked Nov. 6, 2026
Arkansas Blue Cross and Blue ShieldArkansasSaid “weight loss drugs are not a covered benefit” and listed Zepbound as not covered. We found no newer policy, so check your plan’s own list.Providers’ News, December 2023; checked Nov. 6, 2026
Blue Shield of CaliforniaCalifornia, where Anthem Blue Cross also sellsExcludes weight-loss drugs, Zepbound included, from certain PPO and HMO plans, some Covered California plans among them, since Jan. 1, 2025 or renewal. It still covers them for Class III obesity with a weight-loss program.Fact sheet, November 2024; checked Nov. 15, 2026
CareFirst BlueCross BlueShieldMaryland, D.C. and VirginiaWe found no public CareFirst policy on Zepbound for weight loss. A federal court ruled that its and CVS Caremark’s exclusion of Zepbound for sleep apnea didn’t violate ERISA, Bloomberg Law reported.Bloomberg Law, June 11, 2026; read Nov. 18, 2026
Florida BlueFloridaIts commercial plans cover GLP-1s only for type 2 diabetes and exclude weight-loss drugs, Zepbound named. State employees in the state’s Florida Blue plan get them in 2026 only through a state pilot.Provider notice, January 2025, effective April 1, 2025; read Nov. 18, 2026
Blue Cross and Blue Shield of IllinoisIllinoisSays most of its plans don’t cover GLP-1s for weight loss. Where Prime Therapeutics runs your drug benefit, weight-loss drugs aren’t a standard benefit.Ask BCBSIL FAQ; update, Jan. 8, 2026; checked Nov. 6, 2026
Wellmark Blue Cross and Blue ShieldIowa and South DakotaCalls weight-loss drugs “a standard exclusion for most benefit plans.” If your plan includes them, Zepbound is covered with prior authorization when criteria are met, 12 months at a time.Policy 05.04.33, effective Sept. 1, 2026; checked Nov. 6, 2026
Blue Cross Blue Shield of MassachusettsMassachusettsAs plans renew from Jan. 1, 2026, GLP-1s are covered only for type 2 diabetes; Zepbound is excluded, even for sleep apnea, unless your employer buys a rider. It says it isn’t making exceptions.Coverage update, May 29, 2025, read Nov. 18, 2026; fact sheet, January 2026, checked Nov. 6, 2026
Blue Cross Blue Shield of Michiganand Blue Care Network, MichiganEnded weight-loss GLP-1 coverage for fully insured large groups on Jan. 1, 2025, or at renewal; self-funded groups decide. Its 2026 drug list says Zepbound “may not be covered by your plan.”The Record, July 2024; Premium Drug List, November 2026, checked Nov. 6, 2026
Blue Cross and Blue Shield of MinnesotaMinnesotaApproves Zepbound for weight management only if your pharmacy benefit doesn’t exclude weight loss; then BMI rules and at least 6 months of diet, activity and behavior changes.Program summary, effective Jan. 1, 2026; checked Nov. 6, 2026
Blue Cross and Blue Shield of NebraskaNebraskaIts Weight-Loss Drug Therapy program, for plans that include it, covers Zepbound, Wegovy and Saxenda. The State of Nebraska plan it runs doesn’t cover weight-loss drugs.Program FAQ; State of Nebraska FAQ, July 1, 2026; checked Nov. 6, 2026
Excellus BlueCross BlueShieldNew York, one of four Blue companies there“Contract dependent.” Where your contract covers it: a BMI of 40, or 35 with a listed condition, 3 months in a weight program and a Foundayo trial first. Zepbound vials and KwikPens aren’t covered.Policy PHARMACY-03, reviewed Aug. 24, 2026; checked Nov. 6, 2026
Blue Cross Blue Shield of North DakotaNorth DakotaFrom Jan. 1, 2026, at each renewal, fully insured, non-grandfathered large-group plans drop weight-loss drugs and self-funded employers choose. Individual and small-group metal plans keep them under state rules.Coverage changes for 2026, Aug. 7, 2025; read Nov. 18, 2026
Blue Cross and Blue Shield of OklahomaOklahomaFor self-funded groups, weight-loss GLP-1 coverage is optional. Groups that elect it keep the Zepbound auto-injector covered; the KwikPen is excluded.Employer news, May 22, 2026, updated Nov. 13, 2026; read Nov. 18, 2026
Regence BlueCross BlueShieldOregon, Utah, Idaho and WashingtonCoverage “is defined by benefit contract language”: no approval if your contract excludes obesity treatment. Where covered, a BMI of 30, or 27 with a weight-related condition.Policy dru787, effective Aug. 15, 2026; checked Nov. 6, 2026
HighmarkPennsylvania, Delaware, West Virginia and New YorkHas a Standard and an Enhanced anti-obesity drug policy, the Standard one with its own Zepbound criteria, and doesn’t say which plans use which. Ask Highmark or HR.Formulary update, January 2026; checked Nov. 6, 2026
Independence Blue CrossPennsylvaniaSince Jan. 1, 2025, no coverage of drugs used “solely for weight loss” for fully insured group and individual members; GLP-1s stay covered for other approved uses, with prior authorization.Provider notice, effective Jan. 1, 2025; checked Nov. 6, 2026
BlueCross BlueShield of South CarolinaSouth CarolinaWhere a commercial plan excludes weight-loss GLP-1s, Zepbound for sleep apnea “will not be reviewed for medical necessity”; Wegovy can still be covered for heart risk or MASH.Bulletin, Sept. 10, 2026, in effect Aug. 1, 2026; read Nov. 18, 2026
BlueCross BlueShield of TennesseeTennesseeLists services or supplies “for weight loss or to treat obesity” among its general exclusions, which “may vary between products and plans.”Provider manual, effective Oct. 1, 2026; checked Nov. 6, 2026
Blue Cross and Blue Shield of VermontVermontStopped covering GLP-1s approved for weight loss, Zepbound included, on Jan. 1, 2026. Diabetes GLP-1s, and Wegovy for heart disease with obesity, stay covered with prior approval.GLP-1 FAQ, changes effective Jan. 1, 2026; read Nov. 18, 2026
Premera Blue CrossWashington and AlaskaCovers weight-loss GLP-1s “only when an employer group elects this benefit,” with prior authorization; employers can cap the benefit at $9,000 a year.Employer news, Feb. 19, 2026; benefit options, June 19, 2026; checked Nov. 6, 2026
FEP Bluefederal employees and retirees, nationwide2027 Standard and Basic drug lists put Zepbound in the chart of drugs not covered; Wegovy is Tier 3 with prior approval. Focus lists neither.2027 drug lists, effective Jan. 1, 2027; read Nov. 1, 2026

What 22 Blue companies and FEP Blue say about Zepbound for weight loss, with each policy’s date and the date we checked it. Your plan documents decide.

Why it varies

Why does the answer depend on your state’s Blue plan?

Because each Blue company is its own insurer. The Blue Cross Blue Shield Association licenses the Blue names to 33 independent, locally operated companies, and each one “offers its own set of plans, benefits and member resources” (BCBSA, read Nov. 18, 2026). Your employer’s choices and your pharmacy benefit narrow it further.

Why Blue coverage of Zepbound differs, from BCBSA’s pages (read Nov. 18, 2026) and the Blue companies’ own notices
Who sets coverageYour Blue company. BCBSA owns the Blue names and licenses them for exclusive areas; its pages don’t describe it setting drug coverage.
More than one Blue in a stateCalifornia, Idaho, Missouri, New York, Pennsylvania, Virginia and Washington each list two or more Blue companies. Anthem holds the Blue license in 14 states.
Self-funded job plansYour employer pays the claims and chooses whether weight-loss drugs are covered: BCBSOK, Premera and North Dakota’s Blue all say so.
Fully insured plansThe Blue company’s rule applies; AZ Blue and Blue Cross Blue Shield of Massachusetts let employers buy a rider that adds weight-loss drugs back.
Individual and small-group plansState rules matter: North Dakota’s Blue keeps weight-loss drugs on these plans under the state’s essential health benefit rules, while Independence Blue Cross dropped them in 2025.
Your pharmacy benefitBlue Cross and Blue Shield of Illinois, BCBSOK and Florida Blue work with Prime Therapeutics, a separate company in which BCBSOK and several other Blues hold a stake. Some plans use CVS Caremark’s lists.

Self-funded or fully insured: why does it matter?

It decides who can add the benefit. On a self-funded plan, your employer pays the claims and picks the drug coverage; on a fully insured plan, the Blue company’s policy applies, plus any rider your employer buys. Blue Cross Blue Shield of Michigan ended weight-loss GLP-1 coverage for fully insured large groups on Jan. 1, 2025, while self-funded groups that still cover the drugs can keep their own criteria (provider alert, June 6, 2024). Ask HR which kind you have.

Which Blue company is yours?

The one that issued your plan, not always the one where you live. Your member ID card names it, and BCBS.com can find it from your ZIP code or the first three letters of the ID number on your card; with coverage through work, BCBSA says to search with your workplace ZIP code (read Nov. 18, 2026). A job plan from another state follows that company’s rules.

Step by step

How do you check your Blue plan’s formulary?

Six checks, from your member portal to a written answer you can appeal. Your plan’s own documents decide, so start there.

  1. Sign in to your member portal. Your Blue company’s website or app shows your plan’s drug list, often called the formulary, and your benefit booklet. Search for Zepbound by name.
  2. Check which Zepbound it lists. Plans can cover one form and not another: BCBSOK excludes the KwikPen, and Excellus covers neither vials nor KwikPens. Lilly’s savings card is for the single-dose pen.
  3. Read the letters beside it. PA means prior authorization, QL a quantity limit and ST step therapy, trying another drug first. A benefit-exclusion flag, like the one on Anthem’s list, means your plan may not cover it at all.
  4. Search your plan documents for “weight loss.” If your plan excludes weight-loss drugs, prior authorization can’t change that, Regence’s policy says. Ask HR whether your employer elected the benefit or bought a rider.
  5. Ask your prescriber to request prior authorization. Send your starting BMI, weight-related conditions and any diet or program you’ve done; for sleep apnea, a recent sleep study.
  6. Get the answer in writing. A denial letter shows whether the reason is medical, which you can appeal, or a plan exclusion, which an appeal won’t undo. Then compare self-pay prices.

Six checks, from the member portal to a written answer.

Prior authorization

What prior authorization do Blue plans ask for?

Where a Blue plan covers Zepbound for weight loss, your prescriber has to get approval first. The Blue criteria we read mostly start at a BMI of 30, or 27 with a weight-related condition; some add a diet or program, and approvals last a year or less.

  • BMI 30 or 27 with a weight-related condition, at Regence, Wellmark and Minnesota’s Blue Excellus: 40, or 35 with a condition
  • 6 months of a low-calorie diet, more activity and behavior changes first Blue Cross and Blue Shield of Minnesota
  • 5% weight loss to renew at Minnesota’s Blue and Excellus; at Regence, 5% or a dose still rising Wellmark sets no percentage

Criteria differ by company. Regence also asks for an attestation that you’ll use Zepbound with lifestyle changes (policy dru787, effective Aug. 15, 2026). Wellmark requires a comprehensive weight-management program, with no minimum length (policy 05.04.33, effective Sept. 1, 2026). Excellus asks for at least 3 months in a qualified program, and new starts must try Foundayo first unless your prescriber documents why you can’t (Aug. 24, 2026). Nebraska’s Blue counts a BMI of 30 at any point in the past six months (all checked Nov. 6, 2026).

Approvals end. Wellmark and Minnesota’s Blue approve 12 months at a time, Excellus approves new starts for 7 months, and Regence reviews approvals at least yearly. At Blue Cross Blue Shield of Massachusetts, existing approvals ended at each plan’s 2026 renewal. Ask when yours ends and whether a plan change resets it.

How long does a decision take?

Blue Cross and Blue Shield of Nebraska says a decision can take up to 15 calendar days (checked Nov. 6, 2026). If the answer is no, your plan must tell you why in writing, and you can appeal a decision about medical need (HealthCare.gov).

Sleep apnea

Does Blue Cross Blue Shield cover Zepbound for sleep apnea?

Sometimes, and it can be a separate question from weight loss. Zepbound is FDA-approved for moderate to severe obstructive sleep apnea in adults with obesity, and some Blues review that use on its own; others treat it like a weight-loss use, so a weight-loss exclusion blocks it.

  • Reviewed on its own: AZ Blue keeps a guideline for Zepbound for sleep apnea apart from its weight-loss rider, and Wellmark’s policy has a separate path when sleep apnea is the main reason (checked Nov. 6, 2026).
  • With set criteria: Premera’s policy 5.01.621 asks for a sleep study from the past 12 months showing at least 15 breathing events an hour (checked Nov. 6, 2026).
  • Excluded unless your employer adds it: Blue Cross Blue Shield of Massachusetts excludes Zepbound even for sleep apnea unless an employer bought a rider (fact sheet, January 2026).
  • Not reviewed: BCBS of South Carolina says Zepbound for sleep apnea “will not be reviewed for medical necessity” on commercial plans that exclude weight-loss GLP-1s (bulletin, Sept. 10, 2026; in effect Aug. 1, 2026).

A court sided with a Blue plan. A federal court in Washington, D.C., ruled that CareFirst’s and CVS Caremark’s exclusion of Zepbound for sleep apnea didn’t violate ERISA, the federal law for most private employer plans, Bloomberg Law reported (June 11, 2026). Ask your plan in writing whether it covers Zepbound for sleep apnea before your prescriber files.

On Medicare? People with moderate to severe sleep apnea aren’t eligible for the $50 Bridge. Medicare.gov says to ask your drug plan, which may already cover a GLP-1 for you.

Federal employees

Does the federal employee Blue plan (FEP) cover Zepbound?

Not in 2027 on FEP Blue Standard or Basic. Their 2027 drug lists put Zepbound in the chart of drugs not covered, with Wegovy among the covered options on Tier 3 with prior approval, and FEP Blue Focus lists neither (federal FEHB versions, read Nov. 1, 2026; FEP Blue’s Postal Service PSHB documents are separate). Open Season runs until Dec. 14, 2026. Every plan, compared: FEHB GLP-1 coverage in 2027.

FEP Blue Standard. The Wegovy pen and pill, and Wegovy HD, are Tier 3 with prior approval. Its 2027 brochure puts Tier 3 at 50% of the plan allowance at a Preferred retail pharmacy, or 20% up to $250 for up to 90 days through FEP’s mail service pharmacy.

FEP Blue Basic. Wegovy and Wegovy HD are Tier 3 with prior approval, at 60% of the plan allowance at a Preferred retail pharmacy. Zepbound is in its chart of drugs not covered in 2027.

FEP Blue Focus. The anti-obesity drugs on its 2027 list are liraglutide and orlistat, Tier 1 with prior approval. Wegovy and Zepbound aren’t on it.

OPM’s 2027 rule. Every FEHB and PSHB plan must still cover at least one weight-loss GLP-1, and all carriers will require documented intensive behavioral therapy before and during treatment, OPM says. Changes start in January 2027.

2027

What changes for Blue plans in 2027?

Your Blue plan’s 2027 drug list decides. None of the Blue notices we read on Nov. 18, 2026 announced a 2027 Zepbound change, but FEP Blue’s 2027 lists don’t cover it, and Lilly’s savings card terms end Dec. 31, 2026. These dates can change what you pay.

  1. CVS Caremark returned Zepbound to its most common commercial drug lists as an additional preferred option, “for plan sponsors who elect to provide coverage”; employers can still customize them (CVS Health, May 28, 2026).

  2. HealthCare.gov open enrollment opened for 2027. It runs to Jan. 15, 2027; enroll by Dec. 15 for coverage from Jan. 1. Some states run their own exchanges and dates.

  3. FEHB and PSHB Open Season. FEP Blue’s 2027 Standard and Basic lists don’t cover Zepbound.

  4. Medicare Open Enrollment ends; plan changes start Jan. 1, 2027.

  5. Lilly’s Zepbound savings card and its KwikPen self-pay card end under their current terms; Lilly hadn’t posted 2027 terms on Nov. 15, 2026.

  6. Calendar-year 2027 plans and drug lists begin, and Part D’s yearly out-of-pocket cap rises to $2,400. Ask whether your prior authorization carries into 2027.

  7. Medicare’s GLP-1 Bridge ends, under CMS’s current plan.

Most employers plan to keep coverage. In a February to March 2026 survey, 72% of large employers that cover weight-loss GLP-1s said they’ll likely keep coverage in 2027 and 10% likely won’t (Business Group on Health). What else changes: GLP-1 coverage in 2027.

If it’s a no

What are your options if your Blue plan says no?

Appeal if the denial is about medical need; if your plan excludes weight-loss drugs, ask HR about adding the benefit, switch to a covered drug or pay yourself. Zepbound vials are $299 to $449 a month at LillyDirect, by dose; $449 (7.5 to 15 mg) needs a refill within 45 days, or it’s $499 to $699 (checked Nov. 15, 2026).

Appeal a medical denial. Get the reason in writing, then file an internal appeal within 180 days, with a letter from your prescriber. For care you haven’t had yet, the plan must decide within 30 days. If it still says no, you have 4 months to ask for an external review, decided within 45 days, or 72 hours if it’s urgent (HealthCare.gov). More: when your GLP-1 isn’t covered.

An exclusion is different. External review is for denials that involve medical judgment, so it can’t add a benefit your plan leaves out, and Blue Cross Blue Shield of Massachusetts says its exclusion can’t be appealed. Ask HR whether your employer can elect the benefit or buy a rider, as AZ Blue and Blue Cross Blue Shield of Massachusetts offer.

Switch to what’s covered. Some Blue plans cover Wegovy but not Zepbound, as FEP Blue Standard and Basic do in 2027. Whether a switch fits you is your prescriber’s call. Prices without coverage: Zepbound cost without insurance.

Self-pay prices from LillyDirect, Lilly’s savings-card terms and NovoCare’s terms, read November 1, 2026: the medication alone, with your prescriber’s visit extra. Compounded prices from our GLP-1 price index. Compounded tirzepatide and semaglutide aren’t FDA-approved, aren’t Zepbound or Wegovy, and weren’t studied in those brands’ trials.
OptionA monthGood to know
Zepbound vials at LillyDirect4 vials a month$299 to $449$449 from 7.5 mg if you refill within 45 days; $499 to $699 if not. No end date listed. The KwikPen is the same price today, through a Lilly self-pay card whose terms end December 31, 2026
Wegovy pen through NovoCare0.25 to 2.4 mg$349$399 for Wegovy HD. New patients: $199 for each of their first two fills (through Dec. 31, 2026), with the prescription written and received by that date
Wegovy pill through NovoCare30 tablets$149 to $299By dose
Compounded tirzepatideonline programs; not FDA-approved$126 to $599Month to month, all in: median $285 across 25 programs, checked Nov. 15, 2026
Compounded tirzepatide at NexLife$115 or $129$115 a month on the 12-month plan (paid upfront: $1,380), or $129 month to month (billed monthly); the same at every dose

Swipe the table sideways to see every column.

Self-pay prices from LillyDirect, Lilly’s savings-card terms and NovoCare’s terms, read November 1, 2026: the medication alone, with your prescriber’s visit extra. Compounded prices from our GLP-1 price index. Compounded tirzepatide and semaglutide aren’t FDA-approved, aren’t Zepbound or Wegovy, and weren’t studied in those brands’ trials.

NexLife Price Match Guarantee†. Already on compounded tirzepatide or semaglutide with another licensed provider, and paying less? We match your regular monthly price. How it works

The makers’ self-pay rules. Novo’s self-pay terms say you can’t bill your plan for these purchases or count them toward a deductible.

At NexLife, compounded tirzepatide is $115 a month on the 12-month plan, $119 (6-month), $125 (3-month) or $129 month to month. Compounded semaglutide is $95 a month on the 12-month plan, $99 (6-month), $105 (3-month) or $109 month to month. Both are the same price at every dose, with no membership fee. NexLife is self-pay only, so it doesn’t bill your Blue plan.

How it’s billed: month to month is billed once a month. The 3-, 6- and 12-month plans are paid upfront, in full, at checkout: $375, $714 or $1,380 for tirzepatide, and $315, $594 or $1,140 for semaglutide. A longer plan starts only if you’re prescribed.

Ways to pay: NexLife takes HSA and FSA cards and provides a letter of medical necessity if your plan asks for one. Affirm, Klarna or Afterpay are offered at checkout; approval is theirs to give.

A licensed provider decides whether compounded tirzepatide or semaglutide is right for you, after reviewing your health history and the dose you take now. The labels pair these medicines with a reduced-calorie diet and more physical activity: here’s what to eat on a GLP-1. Questions? Call or text (949) 818-8000, 24/7.

Every program

What do online programs charge for compounded tirzepatide and semaglutide?

Compounded tirzepatide runs $126 to $599 a month and compounded semaglutide $87 to $399, month to month and all in, in our GLP-1 price index (checked Nov. 15, 2026). Neither is FDA-approved. The medians are $285 and $199.

Compounded tirzepatide and semaglutide in our GLP-1 price index, month to month and all in (medication plus any required membership or program fee), checked Nov. 15, 2026
In our indexCompounded tirzepatideCompounded semaglutide
Month-to-month range ($ a month, all in)$126 to $599$87 to $399
Median ($ a month)$285$199
Programs that publish a month-to-month price2527
Lowest month-to-month priceMondae, $126Mondae, $87
Same price at every dose14 of the 2514 of the 27
Programs in the index’s table4444

NexLife Price Match Guarantee†. Already on compounded tirzepatide or semaglutide with another licensed provider, and paying less? We match your regular monthly price. How it works

How NexLife compares. NexLife, which publishes this guide, charges $129 month to month for compounded tirzepatide, $156 under that median, and $109 for semaglutide, $90 under it. It charges the same at every dose, as 14 of the 25 tirzepatide programs and 14 of the 27 semaglutide programs do.

Not every program shows a price. 18 of the 43 programs selling injectable compounded tirzepatide publish no month-to-month price, so the medians count only the ones that do.

All in means the medication plus any required membership or program fee. Every program, its price and its notes: our GLP-1 price index, checked Nov. 15, 2026. How we read each program’s price: our review methodology.

In their words

What do the Blue association, Zepbound’s label and the FDA say?

Three primary sources behind this page’s answers: how the Blue system works, how the label says Zepbound is used, and what a compounded version is.

Why your own Blue company’s rules decide, in the Blue Cross Blue Shield Association’s words:

“BCBS companies are independent, locally operated organizations.”

Blue Cross Blue Shield Association, How to find your local BCBS company, read Nov. 18, 2026

Where a Blue plan covers Zepbound, its criteria often ask for a diet or a program; the label pairs the medicine with lifestyle changes:

“Administer ZEPBOUND in combination with a reduced-calorie diet and increased physical activity.”

Eli Lilly and Company, Zepbound (tirzepatide) prescribing information, revised August 2026

If your plan won’t pay and you consider a compounded version, know the difference: Zepbound is the FDA-approved brand-name medicine, while a compounded version is made by a pharmacy and isn’t reviewed by the FDA for safety, effectiveness or quality.

“Compounded drugs are not FDA-approved.”

U.S. Food and Drug Administration, Compounding and the FDA: Questions and Answers

Vial math

How many units is your tirzepatide or semaglutide dose?

On a compounded vial, the units depend on its strength. Here are the label doses at example strengths, with the math to check your own.

Tirzepatide

Tirzepatide doses on Zepbound’s label, with the volume and units on a U-100 syringe at an example strength of 25 mg per mL; your vial’s label decides
DosemL at 25 mg/mLUnits (U-100)On the label
2.5 mg0.1 mL10 unitsStarting dose, for 4 weeks
5 mg0.2 mL20 unitsA maintenance dose
7.5 mg0.3 mL30 unitsA step up
10 mg0.4 mL40 unitsA maintenance dose
12.5 mg0.5 mL50 unitsA step up
15 mg0.6 mL60 unitsThe maximum, and a maintenance dose

The math: mL = dose ÷ strength (mg per mL), and units = mL × 100. At 25 mg/mL, 10 mg is 10 ÷ 25 = 0.4 mL, or 40 units.

Semaglutide

Semaglutide dose steps from the Wegovy label, with the volume and units on a U-100 syringe at two example strengths, 2.5 mg/mL and 5 mg/mL
WeeksWeekly doseAt 2.5 mg/mLAt 5 mg/mL
1 to 40.25 mg0.1 mL (10 units)0.05 mL (5 units)
5 to 80.5 mg0.2 mL (20 units)0.1 mL (10 units)
9 to 121 mg0.4 mL (40 units)0.2 mL (20 units)
13 to 161.7 mg0.68 mL (68 units)0.34 mL (34 units)
17 onward2.4 mg0.96 mL (96 units)0.48 mL (48 units)

The math: mL = dose ÷ strength (mg per mL); units = mL × 100. At 2.5 mg/mL, 1 mg is 1 ÷ 2.5 = 0.4 mL, or 40 units. At 5 mg/mL, the same 1 mg is 0.2 mL, or 20 units.

25 mg per mL is an example only: it’s the strength of the 15 mg multi-dose vial on Zepbound’s label (15 mg per 0.6 mL). Read the strength on your own vial’s label; your provider sets your dose, in steps at least 4 weeks apart. Every step: the tirzepatide dosage chart. Or enter your own vial’s strength in the tirzepatide and semaglutide dosage calculator. Both strengths are examples only. The same dose is a different number of units at a different strength, so read the strength on your own vial’s label. Your prescription sets your dose and schedule, which may differ from these label steps. Every step: the semaglutide dosage chart.

What does NexLife cost?
One flat price at every dose.

No membership fee. Provider care, a nutrition plan, coaching and shipping are included.

Illustration of a compounded tirzepatide vialGIP + GLP-1

12-month plan $115/mo

Tirzepatide

Weekly and dual-action. Care, coaching and shipping included. On a 12-month plan, $1,380 paid upfront; $129/mo month to month, billed monthly.

Check my eligibility

Compounded, not FDA-approved · Not prescribed? No charge for medication

Illustration of a compounded semaglutide vialGLP-1

12-month plan $95/mo

Semaglutide

Weekly GLP-1. Care, coaching and shipping included. On a 12-month plan, $1,140 paid upfront; $109/mo month to month, billed monthly.

Check my eligibility

Compounded, not FDA-approved · Not prescribed? No charge for medication

TrustScore 4.8 out of 5 on Trustpilot 407 reviews as of Nov. 15, 2026 · Read them all ↗

Compounded, not FDA-approved. A licensed provider prescribes it only when it offers a significant difference for you. Vials shown are illustrations. Always use the strength on your pharmacy’s label. Every plan and price · Price Match Guarantee† terms

Blue Cross Blue Shield and Zepbound: your questions

Fair questions about NexLife

Will my price go up with my dose?
No. You pay the same at every dose.
What if I’m not prescribed?
You aren’t charged for medication.
Can I cancel?
Yes, by email. It takes effect 30 days after we receive it. Plans renew until you cancel; our cancellation policy has the details.
Do I need insurance?
No. Pay with an HSA or FSA card, or with Affirm, Klarna or Afterpay at checkout.

Does Blue Cross Blue Shield cover Zepbound?

It depends on your Blue company and your plan. The 33 independent Blue companies set their own drug coverage, and on job plans your employer often decides whether weight-loss drugs are covered. Florida Blue (in a January 2025 notice) and Blue Cross and Blue Shield of Vermont (since Jan. 1, 2026) exclude them, for example, while Wellmark and Regence cover Zepbound with prior authorization when your plan includes weight-loss drugs. Check your member portal’s drug list and your plan documents.

Does Blue Cross cover Zepbound for sleep apnea?

Sometimes. Zepbound is FDA-approved for moderate to severe obstructive sleep apnea in adults with obesity, and some Blues review that use on its own: AZ Blue keeps a separate guideline, and Wellmark has a separate path when sleep apnea is the main reason. Premera’s sleep apnea criteria include a sleep study from the past 12 months. Blue Cross Blue Shield of Massachusetts excludes it even for sleep apnea unless your employer bought a rider (January 2026), and BlueCross BlueShield of South Carolina won’t review it where weight-loss drugs are excluded (since Aug. 1, 2026).

Does Anthem Blue Cross Blue Shield cover Zepbound?

It depends on your plan. On Anthem’s National Drug List, current Oct. 1, 2026, Zepbound is tier 2 with prior authorization and quantity limits, but flagged as a possible benefit exclusion, so your plan’s design decides. Anthem’s Georgia individual drug lists for 2026 and 2027 don’t include it (checked Nov. 6, 2026). Anthem holds the Blue license in 14 states, so check your own plan’s list.

Does FEP Blue cover Zepbound in 2027?

Not on FEP Blue Standard or Basic: their 2027 drug lists put Zepbound in the chart of drugs not covered, with Wegovy on Tier 3 with prior approval. FEP Blue Focus lists neither (drug lists read Nov. 1, 2026). Every FEHB and PSHB plan must still cover at least one weight-loss GLP-1 in 2027, OPM says, and Open Season runs until Dec. 14, 2026.

Does Blue Cross Blue Shield Medicare cover Zepbound?

Not for weight loss alone. If you have Part D, including through a Blue Medicare Advantage plan, Medicare’s GLP-1 Bridge, which CMS runs outside your plan, can cover the Zepbound KwikPen for $50 a month through Dec. 31, 2027, with prior authorization, if you meet its BMI and health rules. Zepbound vials and single-dose pens aren’t eligible, Blue Cross Blue Shield of Michigan’s Medicare alert notes (July 1, 2026).

What prior authorization does Blue Cross need for Zepbound?

Where your plan covers it, usually a BMI of 30 or more, or 27 or more with a weight-related condition, as at Regence (Aug. 15, 2026), Wellmark (Sept. 1, 2026) and Blue Cross and Blue Shield of Minnesota (Jan. 1, 2026). Some ask for more: Minnesota’s Blue wants at least 6 months of a low-calorie diet with more activity, and Excellus a BMI of 40, or 35 with a condition, plus a Foundayo trial first (Aug. 24, 2026). Your prescriber files the request.

How much does Zepbound cost with Blue Cross Blue Shield?

It depends on your plan’s tier, copay or coinsurance, and deductible. If your Blue plan covers the single-dose pen, Lilly’s savings card can bring a fill to as little as $25, with up to $100 off a month, under terms that end Dec. 31, 2026 (Lilly hadn’t posted 2027 terms on Nov. 15, 2026). Without coverage, LillyDirect sells vials for $299 to $449 a month by dose; the $449 needs a refill within 45 days (checked Nov. 15, 2026).

Why did my Blue plan stop covering Zepbound?

Usually because your plan dropped weight-loss drugs at renewal. Blue Cross Blue Shield of Michigan ended that coverage for fully insured large groups on Jan. 1, 2025 or at renewal; Blue Cross Blue Shield of Massachusetts and Blue Cross and Blue Shield of Vermont from Jan. 1, 2026; and Blue Cross Blue Shield of North Dakota for fully insured large groups from Jan. 1, 2026. Vermont’s Blue cites cost and premium affordability. Self-funded employers make their own choice.

Can I appeal a Blue Cross Zepbound denial?

Yes, if the denial is about medical need: get the reason in writing, file an internal appeal within 180 days with a letter from your prescriber, then ask for an external review within 4 months if it’s still no (HealthCare.gov). If your plan excludes weight-loss drugs, an appeal won’t add the benefit: Blue Cross Blue Shield of Massachusetts says its exclusion can’t be appealed. Ask HR whether your employer can add it.

Does Blue Cross Blue Shield cover compounded tirzepatide?

Generally no: the Blue policies we read name FDA-approved brand-name medicines such as Zepbound and Wegovy. Compounded tirzepatide is made by a pharmacy, isn’t FDA-approved and isn’t reviewed by the FDA for safety, effectiveness or quality. Nebraska’s Blue program, for one, includes only Zepbound, Wegovy and Saxenda. At NexLife, which is self-pay, compounded tirzepatide is $115 a month on the 12-month plan or $129 month to month, at every dose, and you can pay with an HSA or FSA card.

Will Blue Cross cover Zepbound in 2027?

Only your plan’s 2027 drug list can say. None of the Blue notices we read on Nov. 18, 2026 announced a 2027 Zepbound change, but FEP Blue’s 2027 lists don’t cover it, and Lilly’s savings card terms end Dec. 31, 2026, with no 2027 terms posted as of Nov. 15, 2026. Check your drug list during open enrollment, and ask whether your prior authorization carries into 2027.

Does NexLife take Blue Cross Blue Shield insurance?

No. NexLife is self-pay and doesn’t bill Blue plans: compounded tirzepatide, which isn’t FDA-approved, is $115 a month on the 12-month plan, or $129 month to month, at every dose. You can pay with an HSA or FSA card, and NexLife provides a letter of medical necessity if your plan asks for one.

Important safety information

Compounded tirzepatide and semaglutide are not FDA-approved, and the FDA hasn’t reviewed them for safety, effectiveness or quality. A provider prescribes them only when they offer a significant difference for you compared with an FDA-approved product. Both medicines may cause thyroid tumors, including cancer: don’t use either if you or a family member has had medullary thyroid carcinoma (MTC), or if you have multiple endocrine neoplasia syndrome type 2 (MEN 2). The most common side effects include nausea, diarrhea, vomiting, constipation and stomach pain.

Read the full safety information

In studies with rodents, both medicines caused thyroid tumors; it isn’t known whether they cause them in people. Tell your provider if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath. Serious side effects can include inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar (especially with insulin or sulfonylureas), kidney problems from dehydration, severe stomach problems, serious allergic reactions, vision changes in people with type 2 diabetes, and a faster heart rate. The FDA warned on Nov. 9, 2026, that GLP-1 medicines may raise the risk of NAION, a rare eye condition that can cause sudden vision loss in one eye; call your provider right away if that happens (FDA). Tell your care team before any surgery or procedure that uses anesthesia or deep sedation. Don’t combine either medicine with other GLP-1 medicines.

Tirzepatide can make birth control pills less effective: switch to a non-oral method, or add a barrier method such as condoms, for 4 weeks after you start and for 4 weeks after each dose increase. Both medicines may harm an unborn baby. Semaglutide should be stopped at least 2 months before a planned pregnancy. Tell your provider right away if you’re pregnant, planning to be, or breastfeeding.

This is a summary, not the complete safety information. Read the full Prescribing Information for FDA-approved tirzepatide (Zepbound) and semaglutide (Wegovy), and talk with your provider. You can report side effects to the FDA at 1-800-FDA-1088 or fda.gov/medwatch.

† NexLife Price Match Guarantee: for new NexLife members switching from a licensed U.S. telehealth provider or clinic with an active prescription for compounded tirzepatide or semaglutide. We match your regular all-in monthly price there (medication plus any required membership, program or visit fee, on a month-to-month plan); first-month offers, coupons, referral credits and prepaid multi-month rates aren’t matched. Proof from the last 60 days required. A licensed provider must determine that treatment is right for you. Not open to people with Medicare, Medicaid or TRICARE coverage. Full terms.

About NexLife. NexLife is a telehealth and care-coordination platform. Care is delivered through affiliated, physician-owned medical groups, and licensed providers decide whether treatment is right for you. NexLife doesn’t make or compound medication: state-licensed partner pharmacies fill each prescription, and we coordinate the rest. Available only in states where our affiliated providers are licensed.

Who wrote and medically reviewed this page?

Adam Kennah, MDMedical Director, NexLife · Board-certified in emergency medicine (American Board of Emergency Medicine) · NPI 1144260043

Leads the NexLife Medical Team, which writes and medically reviews NexLife’s guides, including this one.

NexLife Medical TeamWrites and updates NexLife’s guides

Blue company policies checked Nov. 6 to Nov. 18, 2026; FEP Blue’s 2027 drug lists read Nov. 1, 2026; self-pay and compounded prices checked Nov. 15, 2026.

  • How we checked. Each Blue company’s rules come only from its own notices, policies, drug lists and FAQs, with the date each shows. We read six of them on Nov. 18, 2026; the rest were checked on Nov. 6 or Nov. 15, 2026, for NexLife’s state guides. BCBSA’s pages explain how the Blue system works. FEP Blue facts come from its 2027 brochure and drug lists, and OPM; Medicare’s Bridge rules from Medicare.gov and CMS; appeal rules from HealthCare.gov; the CareFirst ruling from Bloomberg Law’s report. Self-pay prices are the makers’ own. A policy can differ from your plan’s contract, so your plan documents decide. We don’t suggest any Blue plan covers NexLife.
  • Every fact, sourced. Each price and rule links to the page it comes from.
  • How we make money. NexLife is a telehealth and care-coordination platform. We earn revenue when people join NexLife.
  • Corrections, fast. See something wrong or out of date? Email hello@nexlife.us and we’ll fix it.
  • How we work. How we review programs · GLP-1 price index · Is NexLife legit? · States NexLife serves

Plan won’t cover your GLP-1 in 2027? Here’s one option.

A 3-minute online check, then a licensed provider decides if compounded tirzepatide is right for you. It’s $115 a month on the 12-month plan, or $129 month to month, at every dose.

4.8 out of 5 on Trustpilot, 407 reviews (read Nov. 15, 2026) · Medical director Adam Kennah, MD (NPI 1144260043) · LegitScript-certified

Compounded medications aren’t FDA-approved. A provider prescribes one only when it offers a significant difference for you.

  1. 1
    Tell us about you

    Start online with your health history.

  2. 2
    A licensed provider decides

    Online, following your state’s rules. You’re prescribed only if treatment is right for you.

  3. 3
    We ship it, then stay with you

    Our partner pharmacy usually ships within 1 to 2 business days. Free shipping, and questions come to us 24/7, never to the pharmacy.

Sources

  1. Blue Cross Blue Shield Association: The Blue Cross and Blue Shield System. Read Nov. 18, 2026.
  2. Blue Cross Blue Shield Association: How to find your local BCBS company. Read Nov. 18, 2026.
  3. Blue Cross Blue Shield Association: Local Blue Cross and Blue Shield companies and licensees. Read Nov. 18, 2026.
  4. Anthem Blue Cross and Blue Shield: National Drug List, four-tier drug plan (current Oct. 1, 2026). Checked Nov. 6, 2026.
  5. Anthem: 2026 Georgia Select drug list for individual plans. Checked Nov. 6, 2026.
  6. Anthem: Georgia drug lists. Checked Nov. 6, 2026.
  7. AZ Blue: Weight Loss Drug List (revised Nov. 5, 2026). Checked Nov. 6, 2026.
  8. AZ Blue: Pharmacy coverage guidelines, including Zepbound for sleep apnea. Checked Nov. 6, 2026.
  9. Arkansas Blue Cross and Blue Shield: Providers’ News, December 2023. Checked Nov. 6, 2026.
  10. Blue Shield of California: Weight loss medication coverage change fact sheet (November 2024). Checked Nov. 15, 2026.
  11. Bloomberg Law: CareFirst, CVS beat lawsuit over Zepbound sleep apnea exclusion (June 11, 2026). Read Nov. 18, 2026; paywalled after the opening.
  12. Florida Blue: GLP-1 prior authorization requirement for commercial plans (January 2025). Read Nov. 18, 2026.
  13. Blue Cross and Blue Shield of Illinois: GLP-1s for weight loss (Ask BCBSIL). Checked Nov. 6, 2026.
  14. Blue Cross and Blue Shield of Illinois: Pharmacy program quarterly update, changes effective Jan. 1, 2026, part 2 (Jan. 8, 2026). Checked Nov. 6, 2026.
  15. Blue Cross and Blue Shield of Illinois: Pharmacy program quarterly update, changes effective Jan. 1, 2025. Checked Nov. 6, 2026.
  16. Wellmark Blue Cross and Blue Shield: Drugs for weight loss management, policy 05.04.33 (effective Sept. 1, 2026). Checked Nov. 6, 2026.
  17. Blue Cross Blue Shield of Massachusetts: GLP-1 medications for obesity, coverage update (May 29, 2025). Read Nov. 18, 2026.
  18. Blue Cross Blue Shield of Massachusetts: Coverage change, GLP-1 medications (provider fact sheet, January 2026). Checked Nov. 6, 2026.
  19. Blue Cross Blue Shield of Michigan and Blue Care Network: The Record, changes coming for select weight loss drugs for some commercial members. July 2024.
  20. Blue Cross Blue Shield of Michigan and Blue Care Network: Provider alert on weight loss drugs for some commercial members (June 6, 2024). Checked Nov. 6, 2026.
  21. Blue Cross Blue Shield of Michigan and Blue Care Network: 2026 Premium Drug List (November 2026). Checked Nov. 6, 2026.
  22. Blue Cross Blue Shield of Michigan: Provider alert, Medicare GLP-1 Bridge for Medicare Plus Blue and BCN Advantage (July 1, 2026). Checked Nov. 6, 2026.
  23. Blue Cross and Blue Shield of Minnesota: Saxenda, Wegovy and Zepbound coverage exception and formulary exception program summary (effective Jan. 1, 2026). Checked Nov. 6, 2026.
  24. Blue Cross and Blue Shield of Nebraska: Weight-loss drug therapy program FAQ (employer toolkit). Checked Nov. 6, 2026.
  25. State of Nebraska: July 1, 2026 open enrollment webinar FAQ. Checked Nov. 6, 2026.
  26. Excellus BlueCross BlueShield: Weight-related comorbidities policy PHARMACY-03 (reviewed Aug. 24, 2026). Checked Nov. 6, 2026.
  27. Blue Cross Blue Shield of North Dakota: Coverage changes to weight-loss drugs for 2026 (Aug. 7, 2025). Read Nov. 18, 2026.
  28. Blue Cross and Blue Shield of Oklahoma: What’s new in GLP-1 coverage, spring 2026 (May 22, 2026; updated Nov. 13, 2026). Read Nov. 18, 2026.
  29. Regence: Medication policy dru787, GLP-1 drugs for non-diabetic uses (effective Aug. 15, 2026). Checked Nov. 6, 2026.
  30. Highmark: Formulary update, January 2026. Checked Nov. 6, 2026.
  31. Independence Blue Cross: Changes coming to weight loss drug coverage benefits (effective Jan. 1, 2025). Checked Nov. 6, 2026.
  32. BlueCross BlueShield of South Carolina: Commercial GLP-1 coverage updates for expanded FDA-approved indications (Sept. 10, 2026). Read Nov. 18, 2026.
  33. BlueCross BlueShield of Tennessee: Provider administration manual (effective Oct. 1, 2026). Checked Nov. 6, 2026.
  34. Blue Cross and Blue Shield of Vermont: FAQ, 2026 coverage changes for GLP-1 drugs FDA-approved for weight loss. Read Nov. 18, 2026.
  35. Premera: GLP-1s still making headlines, employer news (Feb. 19, 2026). Checked Nov. 6, 2026.
  36. Premera: Standard weight management benefit options (June 19, 2026). Checked Nov. 6, 2026.
  37. Premera: Pharmacy policy 5.01.621, drugs for weight management. Checked Nov. 6, 2026.
  38. FEP Blue: Formulary page, with links to the 2027 drug lists. Read Nov. 1, 2026.
  39. FEP Blue Standard Formulary, effective Jan. 1, 2027 (2027 drug list, FEHB; PDF). Read Nov. 1, 2026.
  40. FEP Blue Basic Formulary, effective Jan. 1, 2027 (2027 drug list, FEHB; PDF). Read Nov. 1, 2026.
  41. FEP Blue Focus Drug Formulary, effective Jan. 1, 2027 (2027 drug list, FEHB; PDF). Read Nov. 1, 2026.
  42. FEP Blue: 2027 FEP Blue Standard and FEP Blue Basic brochure (FEHB). Read Nov. 1, 2026.
  43. OPM: Federal Benefits Open Season Highlights, 2027 plan year. Read Nov. 15, 2026.
  44. CVS Health: CVS Caremark delivers affordability and access to GLP-1 weight management medications with expanded coverage options (May 28, 2026). Read Nov. 15, 2026.
  45. Eli Lilly: Zepbound savings and insurance options. Read Nov. 15, 2026.
  46. LillyDirect: Zepbound self-pay prices. Checked Nov. 15, 2026.
  47. Eli Lilly: Zepbound full terms and conditions (the 45-day refill condition). Read Nov. 15, 2026.
  48. NovoCare: Wegovy savings offer and self-pay terms. Read Nov. 15, 2026.
  49. NovoCare Pharmacy: terms and self-pay prices. Read Nov. 15, 2026.
  50. Medicare.gov: Weight loss drugs (the Medicare GLP-1 Bridge). Read Nov. 15, 2026.
  51. Medicare.gov: Medicare GLP-1 Bridge, GLP-1 drugs for $50 a month (fact sheet, June 2026). Read Nov. 15, 2026.
  52. CMS: Medicare GLP-1 Bridge (page modified July 13, 2026). Read Nov. 15, 2026.
  53. Medicare.gov: How much does Medicare drug coverage cost? (the $2,400 cap in 2027). Read Nov. 15, 2026.
  54. Medicare.gov: Open Enrollment. Read Nov. 1, 2026.
  55. HealthCare.gov: Dates and deadlines for 2027 coverage. Read Nov. 15, 2026.
  56. HealthCare.gov: Internal appeals. Read Nov. 1, 2026.
  57. HealthCare.gov: External review. Read Nov. 1, 2026.
  58. Business Group on Health: 2026 GLP-1 survey. Read Nov. 1, 2026.
  59. Eli Lilly: Zepbound (tirzepatide) prescribing information, revised August 2026.
  60. FDA: Compounding and the FDA, questions and answers.
  61. NexLife: GLP-1 price index. Compounded prices checked Nov. 15, 2026.
  62. NexLife: pricing, every plan.